LXRX insider trading
Lexicon Pharmaceuticals, Inc.
In the past 68 days, 1 insider bought $50K of Lexicon Pharmaceuticals, Inc. stock in 1 open-market purchase. The largest purchase was $50K by Michael Exton (Chief Executive Officer) on Nov 6, 2026.
Insider purchases
| Insider | Value | Holdings | Signal | Traded / filed |
|---|---|---|---|---|
Michael Exton Chief Executive Officer |
$50K 30,064 sh @ $1.66 |
+10.1% | Low
|
Nov 6, 2026 Filed Nov 9, 2026 |
Insider sales
No open-market sales by insiders in this period.
The week's top insider buys, every Monday
Clusters, CEO purchases and the largest buys from the past week's SEC filings. One free email a week.
Unsubscribe any time. No spam, no stock picks.